Compare Edwards Lifesciences Corporation Common Stock (EW) vs NextEra Energy, Inc. (NEE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs NextEra Energy, Inc. — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.21 (market cap $48.56B), while NextEra Energy, Inc. trades at $77.38 (market cap $161.39B). The key difference: NextEra Energy, Inc. is far larger — about 3.3× Edwards Lifesciences Corporation Common Stock's market cap, and NextEra Energy, Inc. pays a 3.22% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | NEE | |
|---|---|---|
Market Cap | $48.56B | $161.39B |
Volume | 6,520,488 | 11,780,955 |
Sector | Health | Utilities |
52-Week High | $95.18 | $97.88 |
52-Week Low | $72.65 | $75.49 |
Enterprise Value | $45.01B | $268.72B |
Typical Hold Time | — | 83 Days |
Dividend Yield | — | 3.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NextEra Energy (NEE) trades at $77.37, up 0.4% on the day, with a bearish technical signal but strong analyst support. Recent earnings show mixed results, with Q1 and Q2 2026 beats but a Q4 2025 miss. The company maintains robust profitability, with a net income margin of 32.4% and ROE of 17.23%. News highlights include participation in the Wolfe Research conference and a major $22.3 billion energy infrastructure project in Texas, signaling growth initiatives amid a challenging market.
Outlook is cautiously optimistic, with a consensus price target of $96.00 offering 24% upside. Risks include rising debt-to-asset ratios and macroeconomic pressures, but strong cash flow and strategic investments in clean energy provide long-term growth potential. Investors should weigh solid fundamentals against near-term technical weakness and sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About NextEra Energy, Inc.
NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →
